# Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases

> **NCT06842316** · — · RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 100 (estimated)

## Conditions studied

- Inflammatory Disorder of Immune System
- Spondylitis, Ankylosing
- Arthritis, Rheumatoid
- Arthritis, Psoriatic
- Inflammatory Bowel Diseases
- Sjogren's Syndrome
- Lupus Erythematosus, Systemic

## Interventions

- **OTHER:** 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease)

## Key facts

- **NCT ID:** NCT06842316
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2027-04-09
- **Final completion:** 2027-04-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842316, "Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06842316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
